Global Health Limited (Medanta) has issued a regulatory intimation to the BSE and NSE stock exchanges. The disclosure is made pursuant to SEBI LODR Regulation 29.
The purpose of the communication is to inform that a meeting of the Company's Board of Directors is scheduled to be held on Tuesday, November 03, 2026. The primary agenda for the meeting is to consider and approve the Unaudited Financial Results of the Company for the Second Quarter and Half Year ended September 30, 2026.
Additionally, the company confirms that its Trading Window for insiders is closed. The closure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the Company's internal Code for Prevention of Insider Trading. The Trading Window was closed effective October 01, 2026. It is stipulated to re-open after 48 hours from the declaration of the aforementioned financial results.
The letter is signed by Rahul Ranjan, Company Secretary & Compliance Officer (Membership No. A17035), on behalf of Global Health Limited.